Compare
Xometry, Inc. vs International Money Express, Inc. vs Nutex Health Inc. vs Claritev Corp
| Latest fiscal year | Xometry, Inc. XMTR | International Money Express, Inc. IMXI | Nutex Health Inc. NUTX | Claritev Corp CTEV |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $686.63M | $607.78M | $875.26M | $965.41M |
| Revenue growth (YoY) | +25.9% | -7.7% | +82.4% | +3.7% |
| Gross margin | 39.1% | n/a | 50.8% | n/a |
| Operating margin | -6.6% | 9.2% | 31.5% | 3.0% |
| Net margin | -9.0% | 5.4% | 8.1% | -29.4% |
| Net income | -$61.75M | $32.67M | $70.79M | -$284.28M |
| EPS (Diluted) | n/a | $1.08 | $10.48 | -$17.30 |
| Operating cash flow | $6.09M | $36.89M | $248.12M | $117.32M |
| Free cash flow | -$24.09M | $15.81M | $245.60M | -$12.28M |
| Cash & equivalents | $15.00M | $168.68M | $185.57M | $16.81M |
| Total assets | $703.72M | $517.69M | $918.52M | $4.89B |
| Total liabilities | $426.98M | n/a | $495.09M | $5.06B |
| Shareholders' equity | $276.74M | $161.05M | $423.44M | -$173.90M |
| Return on year-end equity | -22.3% | 20.3% | 16.7% | n/a |
| Shares outstanding | n/a | 29.72M | 7.09M | 16.55M |
Revenue, most recent five fiscal years
| Fiscal year | Xometry, Inc. | International Money Express, Inc. | Nutex Health Inc. | Claritev Corp |
|---|---|---|---|---|
| Latest | $686.63M Ended 2025-12-31 | $607.78M Ended 2025-12-31 | $875.26M Ended 2025-12-31 | $965.41M Ended 2025-12-31 |
| 1 year earlier | $545.53M Ended 2024-12-31 | $658.65M Ended 2024-12-31 | $479.95M Ended 2024-12-31 | $930.62M Ended 2024-12-31 |
| 2 years earlier | $463.41M Ended 2023-12-31 | $658.74M Ended 2023-12-31 | $247.65M Ended 2023-12-31 | $961.52M Ended 2023-12-31 |
| 3 years earlier | $380.92M Ended 2022-12-31 | $546.80M Ended 2022-12-31 | $219.29M Ended 2022-12-31 | $1.08B Ended 2022-12-31 |
| 4 years earlier | $218.34M Ended 2021-12-31 | $459.21M Ended 2021-12-31 | $331.53M Ended 2021-12-31 | $1.12B Ended 2021-12-31 |